Orthofix Medical has announced US Food and Drug Administration (FDA) approval of the STIM onTrack mobile app version 2.1 for use with the company’s bone growth stimulators.
The STIM onTrack technology works with the Orthofix Bone Growth Therapy devices. The mobile device app is an accessory designed to help patients adhere to their prescriptions and improve their clinical outcomes. The new version of the app hosts Patient Reported Outcome Measure (PROM) questionnaires which enable patients to remotely share the status of their quality of life and functional well-being with their physician. This is in addition to the daily treatment reminders and device usage calendar that allows physicians to remotely view patient data to monitor treatment.
“The new STIM onTrack mobile app version 2.1 is designed to augment treatment with the CervicalStim, SpinalStim and PhysioStim bone growth stimulators by allowing patients to remotely share PROM data, in addition to device-usage data, with their treating physician,” said Kevin Kenny, president of Global Orthofix Spine.
“We know that patients who take an active role in their follow-up care have an overall better recovery experience and outcomes,” said Peter Whang, associate professor, Department of Orthopaedics and Rehabilitation, Yale University School of Medicine (New Haven, USA). “The STIM onTrack mobile app version 2.1 is very beneficial for tracking adherence to their treatment plan, and the addition of the PROM questionnaire feature provides us with even more insights on how the patient is responding in their home setting, not just when they visit our office.”
Prescribing providers have access to their patients’ PROM submissions via the proprietary Orthofix physician portal. Remote patient monitoring CPT codes are potentially available to prescribing practitioners if they meet the requirements for reimbursement. The STIM onTrack mobile app version 2.1 is an upgrade of the original STIM onTrack mobile app that was first introduced in 2017. The app is free and supported by iOS and Android devices.